Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Charcot Marie Tooth Disease Extended NGS Panel Fulgent Genetics United States | 172 | 59 |
|
Athena Diagnostics United States | 1 | 1 |
|
CMT Advanced Evaluation - Axonal Athena Diagnostics United States | 20 | 13 |
|
CMT Advanced Evaluation - Comprehensive Athena Diagnostics United States | 31 | 23 |
|
CMT Advanced Evaluation - Dominant, Axonal Athena Diagnostics United States | 15 | 11 |
|
CMT Advanced Evaluation - Dominant Athena Diagnostics United States | 18 | 13 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Fulgent Genetics United States | 1103 | 676 |
|
Baylor Genetics United States | 842 | 637 |
|
Hereditary Neuropathies NGS Panel Fulgent Genetics United States | 91 | 38 |
|
Comprehensive Eye Disorders NGS Panel Fulgent Genetics United States | 1018 | 459 |
|
Praxis fuer Humangenetik Wien Austria | 1 | 1 |
|
Charcot-Marie-Tooth Neuropathy Type 2A2 MGZ Medical Genetics Center Germany | 1 | 1 |
|
Charcot-Marie-Tooth Neuropathy Type 2A2 (MFN2) MVZ Dr. Eberhard & Partner Dortmund Germany | 1 | 1 |
|
Charcot-Marie-Tooth Neuropathy Type 2A Molecular Genetics Laboratory London Health Sciences Centre Canada | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.